In kidney cancer, the activation of Axl by Gas6 or autocrine signaling leads to tumor cell growth, metastasis, invasion, EMT, angiogenesis, and drug resistance, mainly in a PI3K-Akt-mTOR dependent manner [28,29]. Here, MTOR is linked to neoplasm.